trial · primary record
INCA000585
Immune Thrombocytopenia
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 56 |
| Primary completion | 2028-03-09 |
| Primary endpoint | Number of participants with Treatment-emergent Adverse Events (TEAEs) |
| Registry ID | NCT07104565 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:42:03.103Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07104565
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.